Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Arkan S Sayed-Noor, Bakir K Kadum & Göran O Sjödén. (2010) Bisphosphonate-induced femoral fragility fractures: What do we know?. Orthopedic Research and Reviews 2, pages 27-34.
Read now
Read now
Jörg Schilcher & Per Aspenberg. (2009) Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthopaedica 80:4, pages 413-415.
Read now
Read now
Per Aspenberg. (2008) Bisphosphonate-induced fractures: Nature strikes back?. Acta Orthopaedica 79:4, pages 459-460.
Read now
Read now
Articles from other publishers (44)
H.P. Bögl, K. Michaëlsson, G. Zdolsek, J. Höijer & J. Schilcher. (2020) Increased rate of reoperation in atypical femoral fractures is related to patient characteristics and not fracture type. A nationwide cohort study. Osteoporosis International 31:5, pages 951-959.
Crossref
Crossref
Xiaoyu Tong, Markus K. H. Malo, Inari S. Burton, Jukka S. Jurvelin, Hanna Isaksson & Heikki Kröger. (2017) Histomorphometric and osteocytic characteristics of cortical bone in male subtrochanteric femoral shaft. Journal of Anatomy 231:5, pages 708-717.
Crossref
Crossref
A. KohE. GueradoP. V. Giannoudis. (2017) Atypical femoral fractures related to bisphosphonate treatment. The Bone & Joint Journal 99-B:3, pages 295-302.
Crossref
Crossref
Zeineb Mahjoub, Sonia Jean, Jean-Thomas Leclerc, Jacques P Brown, Dominic Boulet, St?phane Pelet, Charlotte Grondin, Jeannette Dumont, ?tienne L Belzile & Laetitia Michou. (2016) Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data. Journal of Bone and Mineral Research 31:4, pages 767-776.
Crossref
Crossref
Takahito YuasaKatsuhiko MaezawaYu TaniguchiKentaro AritomiKazuo Kaneko. (2015) Atypical Subtrochanteric Femoral Fracture Below an Arthritic Hip. JBJS Case Connector 5:1, pages e1.
Crossref
Crossref
Thomas A. Einhorn, Yelena Bogdan & Paul Tornetta. (2014) Bisphosphonate-Associated Fractures of the Femur. Journal of Orthopaedic Trauma 28:7, pages 433-438.
Crossref
Crossref
Francisco Jos? Tarazona-Santabalbina & Luis Aguilella-Fern?ndez. (2013) Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?. Aging Clinical and Experimental Research 25:5, pages 605-609.
Crossref
Crossref
M.B. Allison, L. Markman, Z. Rosenberg, R.L. Vieira, J. Babb, N. Tejwani & V. Peck. (2013) RETRACTED: Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy. Bone 55:1, pages 113-118.
Crossref
Crossref
Lisa H. Markman, Mary B. Allison, Zehava S. Rosenberg, Renata L. Vieira, James S. Babb, Nirmal C. Tejwani, Shelly A. Im & Valerie Peck. (2013) A Retrospective Review of Patients with Atypical Femoral Fractures While on Long-Term Bisphosphonates: Including Pertinent Biochemical and Imaging Studies. Endocrine Practice 19:3, pages 456-461.
Crossref
Crossref
A. M?ndez-Gil, S. Prat-Fabregat, A. Domingo-Trepat, M. Navarro-L?pez, P. Camacho-Carrasco, A. Carre?o-Delgado, J.A. Zumbado-Dijeres, R. Garc?a-Elvira, M. R?os-Mart?n, R. Garc?a-Tarri?o, O. Ares-Rodr?guez, J.R. Ballesteros-Betancourt & S. Suso-Vergara. (2013) What do we know about atypical fractures in patients on bisphosphonates treatment? A literature review using a case series. Revista Espa?ola de Cirug?a Ortop?dica y Traumatolog?a (English Edition) 57:2, pages 95-105.
Crossref
Crossref
A. Méndez-Gil, S. Prat-Fabregat, A. Domingo-Trepat, M. Navarro-López, P. Camacho-Carrasco, A. Carreño-Delgado, J.A. Zumbado-Dijeres, R. García-Elvira, M. Ríos-Martín, R. García-Tarriño, O. Ares-Rodríguez, J.R. Ballesteros-Betancourt & S. Suso-Vergara. (2013) ¿Qué sabemos de las fracturas atípicas en los pacientes en tratamiento con bifosfonatos? Revisión bibliográfica a raíz de una serie de casos. Revista Española de Cirugía Ortopédica y Traumatología 57:2, pages 95-105.
Crossref
Crossref
Loredana Cavalli & Maria Luisa Brandi. (2014) Periprosthetic bone loss: diagnostic and therapeutic approaches. F1000Research 2, pages 266.
Crossref
Crossref
Loredana Cavalli & Maria Luisa Brandi. (2013) Periprosthetic bone loss: diagnostic and therapeutic approaches. F1000Research 2, pages 266.
Crossref
Crossref
George P. Lyritis. (2012) FRACTURE HEALING AND ANTIOSTEOPOROTIC TREATMENT. Osteoporosis and Bone Diseases 15:3, pages 41-44.
Crossref
Crossref
Anas Alfahad, Ei Mon Thet, Fawzy Radwan, Joe Sudhakar, Khin Nini & Phaedra Tachtatzis. (2012) Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report. Journal of Medical Case Reports 6:1.
Crossref
Crossref
Hsuan-Ti Huang, Lin Kang, Peng-Ju Huang, Yin-Chih Fu, Sung-Yen Lin, Chih-Hsin Hsieh, Jian-Chih Chen, Yuh-Min Cheng & Chung-Hwan Chen. (2012) Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman. Menopause 19:12, pages 1360-1363.
Crossref
Crossref
Andreas Seraphim, Nawfal Al-Hadithy, Simon C. Mordecai & Shafic Al-Nammari. (2012) Do bisphosphonates cause femoral insufficiency fractures?. Journal of Orthopaedics and Traumatology 13:4, pages 171-177.
Crossref
Crossref
Chih-Ming Kao, Peng-Ju Huang, Chung-Hwan Chen, Shu-Jung Chen & Yuh-Min Cheng. (2012) Atypical femoral fracture after long-term alendronate treatment: Report of a case evidenced with magnetic resonance imaging. The Kaohsiung Journal of Medical Sciences 28:10, pages 555-558.
Crossref
Crossref
Mark L. Prasarn, Jaimo Ahn, David L. Helfet, Joseph M. Lane & Dean G. Lorich. (2012) Bisphosphonate-associated Femur Fractures Have High Complication Rates with Operative Fixation. Clinical Orthopaedics and Related Research? 470:8, pages 2295-2301.
Crossref
Crossref
M. B. CrossD. NamM. C. H. van der MeulenM. P. G. Bostrom. (2012) A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. The Journal of Bone and Joint Surgery. British volume 94-B:7, pages 994-997.
Crossref
Crossref
Fahad Alshahrani & David Kendler. (2012) Femoral Fractures in Osteoporotic Patients on Bisphosphnates. A Case Report. Journal of Clinical Densitometry 15:3, pages 380-384.
Crossref
Crossref
Maria P Yavropoulou, Andrea Giusti, Sharita R Ramautar, Sander Dijkstra, Neveen AT Hamdy & Socrates E Papapoulos. (2012) Low‐energy fractures of the humeral shaft and bisphosphonate use. Journal of Bone and Mineral Research 27:6, pages 1425-1431.
Crossref
Crossref
Renata La Rocca VieiraZehava Sadka RosenbergMary B. AllisonShelly A. ImJames BabbValerie Peck. (2012) Frequency of Incomplete Atypical Femoral Fractures in Asymptomatic Patients on Long-Term Bisphosphonate Therapy. American Journal of Roentgenology 198:5, pages 1144-1151.
Crossref
Crossref
R. N. ThompsonJ. R. A. PhillipsS. H. J. McCauleyJ. R. M. ElliottC. G. Moran. (2012) Atypical femoral fractures and bisphosphonate treatment. The Journal of Bone and Joint Surgery. British volume 94-B:3, pages 385-390.
Crossref
Crossref
Rami El Rachkidi, Marie-Laure Sari-Leret & Stephane Wolff. (2011) Atypical Bilateral Pedicle Fracture in Long-Term Bisphosphonate Therapy. Spine 36:26, pages E1769-E1773.
Crossref
Crossref
Zehava Sadka RosenbergRenata La Rocca VieiraSarah S. ChanJames BabbYakup AkyolLeon D. RybakSandra MooreJenny T. BencardinoValerie PeckNirmal C. TejwaniKenneth A. Egol. (2011) Bisphosphonate-Related Complete Atypical Subtrochanteric Femoral Fractures: Diagnostic Utility of Radiography. American Journal of Roentgenology 197:4, pages 954-960.
Crossref
Crossref
Thomas Funck-Brentano, Emmanuel Biver, Florence Chopin, Beatrice Bouvard, Guillaume Coiffier, Jean-Claude Souberbielle, Patrick Garnero & Christian Roux. (2011) Clinical Utility of Serum Bone Turnover Markers in Postmenopausal Osteoporosis Therapy Monitoring: A Systematic Review. Seminars in Arthritis and Rheumatism 41:2, pages 157-169.
Crossref
Crossref
J.R. Caeiro-Rey, I. Etxebarria-Foronda & M. Mesa-Ramos. (2011) Atypical fractures associated with the long term use of bisphosphonates. The current situation. Revista Española de Cirugía Ortopédica y Traumatología (English Edition) 55:5, pages 392-404.
Crossref
Crossref
J.R. Caeiro-Rey, I. Etxebarria-Foronda & M. Mesa-Ramos. (2011) Fracturas atípicas relacionadas con el uso prolongado de bifosfonatos. Estado de la situación. Revista Española de Cirugía Ortopédica y Traumatología 55:5, pages 392-404.
Crossref
Crossref
Mikko T. Ovaska, Tatu J. Mäkinen & Rami Madanat. (2011) Simultaneous bilateral subtrochanteric fractures following risedronate therapy. Journal of Orthopaedic Science 16:4, pages 467-470.
Crossref
Crossref
R. Rizzoli, K. Åkesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster & C. Cooper. (2010) Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporosis International 22:2, pages 373-390.
Crossref
Crossref
Joseph D. Isaacs, Louis Shidiak, Ian A. Harris & Zoltan L. Szomor. (2010) Femoral Insufficiency Fractures Associated with Prolonged Bisphosphonate Therapy. Clinical Orthopaedics & Related Research 468:12, pages 3384-3392.
Crossref
Crossref
Elizabeth Shane, David Burr, Peter R Ebeling, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David Dempster, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Kenneth Koval, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Howe Tet Sen, Marjolein CH van der Meulen, Robert S Weinstein & Michael Whyte. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research. Journal of Bone and Mineral Research 25:11, pages 2267-2294.
Crossref
Crossref
Vishal C. Patel & Adam M. Lazzarini. (2010) Bilateral Simultaneous Femoral Diaphyseal Fractures in a Patient with Long-Term Ibandronate Use. Orthopedics 33:10.
Crossref
Crossref
Andrea Giusti, Neveen A.T. Hamdy & Socrates E. Papapoulos. (2010) Atypical fractures of the femur and bisphosphonate therapy. Bone 47:2, pages 169-180.
Crossref
Crossref
Katerina Cermak, Felix Shumelinsky, Jean Alexiou & Michael J. Gebhart. (2009) Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy. Clinical Orthopaedics and Related Research? 468:7, pages 1991-1996.
Crossref
Crossref
Ginelle A. Schmidt, Kathleen E. Horner, Deanna L. McDanel, Mary B. Ross & Kevin G. Moores. (2010) Risks and benefits of long-term bisphosphonate therapy. American Journal of Health-System Pharmacy 67:12, pages 994-1001.
Crossref
Crossref
Sarah Shock ChanZehava Sadka RosenbergKeith ChanCraig Capeci. (2010) Subtrochanteric Femoral Fractures in Patients Receiving Long-Term Alendronate Therapy: Imaging Features. American Journal of Roentgenology 194:6, pages 1581-1586.
Crossref
Crossref
Clarita V. Odvina, Shiri Levy, Sudhir Rao, Joseph E. Zerwekh & D. S. Rao. (2010) Unusual mid‐shaft fractures during long‐term bisphosphonate therapy. Clinical Endocrinology 72:2, pages 161-168.
Crossref
Crossref
. (2009) Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use. Orthopedics 32:8.
Crossref
Crossref
. (2009) Current Controversies in Bisphosphonate Therapy. Orthopedics 32:7.
Crossref
Crossref
Arkan S. Sayed-Noor & Göran O. Sjödén. (2009) Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy. Clinical Orthopaedics & Related Research 467:7, pages 1921-1926.
Crossref
Crossref
Jeannette Y. Wick. (2009) <b>Spontaneous Fracture: Multiple Causes</b>. The Consultant Pharmacist 24:2, pages 100-112.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:2.
Crossref
Crossref